Literature DB >> 26330191

Monomorphous Plurihormonal Pituitary Adenoma of Pit-1 Lineage in a Giant Adolescent with Central Hyperthyroidism.

Bernardo Dias Pereira1, Luísa Raimundo2, Ozgur Mete3, Ana Oliveira4, Jorge Portugal2, Sylvia L Asa3.   

Abstract

Thyrotropin (TSH)-secreting pituitary adenomas are exceedingly rare at the pediatric age and no cases of co-secretion with other pituitary hormones in these tumors have been described in this age range. We present a case of a monomorphous plurihormonal pituitary adenoma that co-secreted TSH and GH in a pediatric patient. A 13-year-old male presented with increasing height velocity (17.75 cm/year, 9.55SD), weight loss, and visual impairment. Initial biochemical evaluations revealed secondary hyperthyroidism. A giant pituitary tumor compressing the surrounding structures was detected by magnetic resonance, and a transsphenoidal surgery was initially performed. Pathological examinations revealed an atypical, monomorphous plurihormonal Pit-1 lineage tumor with mixed features of silent subtype 3 adenoma and acidophil stem cell adenoma. In the postoperative period, secondary hyperthyroidism recurred with high levels of both GH and IGF1. In addition, due to tumor re-growth, a multimodality treatment plan was undertaken including surgery, somatostatin analogs, and radiotherapy. We report the first pediatric case of a plurihormonal TSH- and GH-secreting pituitary adenoma, further expanding the clinical manifestations of pediatric pituitary tumors. Comprehensive pathological evaluation and close follow-up surveillance are crucial to the prompt delivery of the best therapeutic options in the context of this particularly aggressive pituitary tumor.

Entities:  

Keywords:  Adolescent; Gigantism; Hyperthyroidism; Pituitary tumors

Mesh:

Substances:

Year:  2016        PMID: 26330191     DOI: 10.1007/s12022-015-9395-2

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  47 in total

1.  Hyperthyroidism secondary to a TSH-secreting pituitary adenoma in a 15-year-old male.

Authors:  J M Stanley; S S Najjar
Journal:  Clin Pediatr (Phila)       Date:  1991-02       Impact factor: 1.168

2.  Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.

Authors:  Laure Cazabat; Jérôme Bouligand; Sylvie Salenave; Michèle Bernier; Stephan Gaillard; Fabrice Parker; Jacques Young; Anne Guiochon-Mantel; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

Review 3.  Growth-hormone and prolactin excess.

Authors:  A Colao; G Lombardi
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

4.  The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.

Authors:  Giuseppe Minniti; Marie-Lise Jaffrain-Rea; Mattia Osti; Vincenzo Esposito; Antonio Santoro; Francesca Solda; Patrizia Gargiulo; Guido Tamburrano; Riccardo Maurizi Enrici
Journal:  Clin Endocrinol (Oxf)       Date:  2005-02       Impact factor: 3.478

Review 5.  Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies.

Authors:  Gerald Raverot; Emmanuel Jouanneau; Jacqueline Trouillas
Journal:  Eur J Endocrinol       Date:  2014-03-13       Impact factor: 6.664

6.  GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.

Authors:  N Sanno; A Teramoto; A Matsuno; S Takekoshi; R Y Osamura
Journal:  J Clin Endocrinol Metab       Date:  1995-08       Impact factor: 5.958

7.  Age-related and gender-related occurrence of pituitary adenomas.

Authors:  T Mindermann; C B Wilson
Journal:  Clin Endocrinol (Oxf)       Date:  1994-09       Impact factor: 3.478

Review 8.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

9.  Clinical aspects and therapeutic outcome in thyrotropin-secreting pituitary adenomas: a single center experience.

Authors:  E Macchia; M Gasperi; M Lombardi; L Morselli; A Pinchera; G Acerbi; G Rossi; E Martino
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

10.  A human TSH-secreting adenoma: endocrine, biochemical and morphological studies. Evidence of somatostatin receptors by using quantitative autoradiography. Clinical and biological improvement by SMS 201-995 treatment.

Authors:  M Polak; J Bertherat; J Y Li; M Kujas; M Le Dafniet; H Weizani; R Van Effenterre; J Epelbaum; G Turpin
Journal:  Acta Endocrinol (Copenh)       Date:  1991-04
View more
  7 in total

Review 1.  A 2019 update on TSH-secreting pituitary adenomas.

Authors:  P Beck-Peccoz; C Giavoli; A Lania
Journal:  J Endocrinol Invest       Date:  2019-06-07       Impact factor: 4.256

2.  Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.

Authors:  Ozgur Mete; Karen Gomez-Hernandez; Walter Kucharczyk; Rowena Ridout; Gelareh Zadeh; Fred Gentili; Shereen Ezzat; Sylvia L Asa
Journal:  Mod Pathol       Date:  2016-01-08       Impact factor: 7.842

Review 3.  Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.

Authors:  Ashley B Grossman; Shereen Ezzat; Sylvia L Asa; Ozgur Mete; Michael D Cusimano; Ian E McCutcheon; Arie Perry; Shozo Yamada; Hiroshi Nishioka; Olivera Casar-Borota; Silvia Uccella; Stefano La Rosa
Journal:  Mod Pathol       Date:  2021-05-21       Impact factor: 7.842

4.  Plurihormonal PIT-1-Positive Pituitary Adenomas: A Systematic Review and Single-Center Series.

Authors:  John P Andrews; Rushikesh S Joshi; Matheus P Pereira; Taemin Oh; Alexander F Haddad; Kaitlyn M Pereira; Robert C Osorio; Kevin C Donohue; Zain Peeran; Sweta Sudhir; Saket Jain; Angad Beniwal; Ashley S Chopra; Narpal S Sandhu; Tarik Tihan; Lewis Blevins; Manish K Aghi
Journal:  World Neurosurg       Date:  2021-04-20       Impact factor: 2.210

5.  Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors.

Authors:  Keiko Taniguchi-Ponciano; Sergio Andonegui-Elguera; Eduardo Peña-Martínez; Gloria Silva-Román; Sandra Vela-Patiño; Erick Gomez-Apo; Laura Chavez-Macias; Guadalupe Vargas-Ortega; Laura Espinosa-de-Los-Monteros; Baldomero Gonzalez-Virla; Carolina Perez; Aldo Ferreira-Hermosillo; Etual Espinosa-Cardenas; Claudia Ramirez-Renteria; Ernesto Sosa; Blas Lopez-Felix; Gerardo Guinto; Daniel Marrero-Rodríguez; Moises Mercado
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

6.  Clinical and Therapeutic Characteristics of Pituitary TSH-Secreting Adenoma in Adolescent-Onset Patients: Six Case Studies and Literature Review.

Authors:  Yamei Yang; Jie Liu; Kan Deng; Lin Lu; Huijuan Zhu; Xiaolan Lian; Xinjie Bao; Lian Duan; Yong Yao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-23       Impact factor: 5.555

7.  Central Hyperthyroidism due to Thyroid-Stimulating Hormone-Secreting Pituitary Microadenoma in an Adolescent Boy: Case Report and Review of the Literature.

Authors:  Le Hoang Bao; Nguyen Minh Duc; Phan Cong Chien; Thieu-Thi Tra My; Tran Viet Thang; Tran Quang Nam
Journal:  Case Rep Endocrinol       Date:  2021-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.